Latest Breaking News On - Flyoverture equity inc - Page 1 : comparemela.com

Psychedelics and mental health company The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded Atai in 2018, led the effort with Thiel Capital, the venture capital firm of tech billionaire Peter Thiel. Apeiron Investment Group and Woodline Partners LP also participated. Atai’s portfolio companies are researching 13 different psychedelic and non-psychedelic compounds for the treatment of a wide range of mental health disorders. Atai is an early investor and holds a significant stake in Compass Pathways (NASDAQ: CMPS). Last November, Atai closed a Series C financing round for $125 million. A spokesperson told Benzinga that the company is expected to list on NASDAQ during 2021, but exact dates are still to be confirmed.

United statesDouglas gordonJoshua bartchChristian angermayerPeter thielRyan hartwellApeiron investment groupFlyoverture equity incCredit suisseAtai life sciencesCanadian stock exchangeCure healthHealth canada scheduleThiel capitalInvestment groupWoodline partners